Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

304 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interleukin-17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis.
Wang A, Hornick N, Lim Y, Gehlhausen J, Siegel J, Wang J, Foss F, Lim I, Zubek A, Milstone L, Galan A, King B, Damsky W. Wang A, et al. Among authors: foss f. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e497-e499. doi: 10.1111/jdv.16416. Epub 2020 May 6. J Eur Acad Dermatol Venereol. 2020. PMID: 32249470 No abstract available.
Development or worsening of sarcoidosis associated with IL-17 blockade for psoriasis.
Hornick N, Wang A, Lim Y, Gehlhausen J, Siegel J, Wang J, Foss F, Lim I, Zubek A, Milstone L, Galan A, King B, Damsky W. Hornick N, et al. Among authors: foss f. J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e583-e585. doi: 10.1111/jdv.16451. Epub 2020 May 19. J Eur Acad Dermatol Venereol. 2020. PMID: 32277505 No abstract available.
United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic.
Zic JA, Ai W, Akilov OE, Carter JB, Duvic M, Foss F, Girardi M, Gru AA, Kim E, Musiek A, Olsen EA, Schieke SM, Shinohara M, Zain JM, Geskin LJ. Zic JA, et al. Among authors: foss f. J Am Acad Dermatol. 2020 Aug;83(2):703-704. doi: 10.1016/j.jaad.2020.04.049. Epub 2020 Apr 16. J Am Acad Dermatol. 2020. PMID: 32305443 Free PMC article. No abstract available.
Efficacy and safety of mogamulizumab by patient baseline blood tumour burden: a post hoc analysis of the MAVORIC trial.
Cowan RA, Scarisbrick JJ, Zinzani PL, Nicolay JP, Sokol L, Pinter-Brown L, Quaglino P, Iversen L, Dummer R, Musiek A, Foss F, Ito T, Rosen JP, Medley MC. Cowan RA, et al. Among authors: foss f. J Eur Acad Dermatol Venereol. 2021 Nov;35(11):2225-2238. doi: 10.1111/jdv.17523. Epub 2021 Aug 20. J Eur Acad Dermatol Venereol. 2021. PMID: 34273208 Free PMC article.
FISH Panel for Leukemic CTCL.
Weed J, Gibson J, Lewis J, Carlson K, Foss F, Choi J, Li P, Girardi M. Weed J, et al. Among authors: foss f. J Invest Dermatol. 2017 Mar;137(3):751-753. doi: 10.1016/j.jid.2016.10.037. Epub 2016 Nov 8. J Invest Dermatol. 2017. PMID: 27836797 Free PMC article. No abstract available.
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.
Maruyama D, Jacobsen E, Porcu P, Allen P, Ishitsuka K, Kusumoto S, Narita T, Tobinai K, Foss F, Tsukasaki K, Feldman T, Imaizumi Y, Izutsu K, Morishima S, Yamauchi N, Yuda J, Brammer JE, Kawamata T, Ruan J, Nosaka K, Utsunomiya A, Wang J, Zain J, Kakurai Y, Yamauchi H, Hizukuri Y, Biserna N, Tachibana M, Inoue A, Horwitz SM. Maruyama D, et al. Among authors: foss f. Lancet Oncol. 2024 Dec;25(12):1589-1601. doi: 10.1016/S1470-2045(24)00502-3. Epub 2024 Oct 29. Lancet Oncol. 2024. PMID: 39486432 Clinical Trial.
304 results